Results 41 to 50 of about 28,422 (269)

What's new in the diagnosis and management of food allergy in children? [PDF]

, 2013
This article reviews the recent advances in the diagnosis and management of IgE mediated food allergy in children. It will encompass the emerging technology of component testing; moves to standardization of the allergy food challenge; permissive diets ...
Campbell, DE, Turner, PJ
core   +1 more source

Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile

Frontiers in Pediatrics, 2023
Background Omalizumab is the first biological therapy used to treat moderate-to-severe asthma and certainly the one with the highest number of publications.
G. Fenu, Andrea La Tessa, C. Calogero, E. Lombardi   +3 more
semanticscholar   +1 more source

Revision surgery versus biologic treatment with omalizumab in recurrent chronic rhinosinusitis with nasal polyps: An analysis of cost-utility and clinical outcomes

The World Allergy Organization Journal, 2023
Background Both revision surgery and omalizumab are recommended therapies for the treatment of recurrent chronic rhinosinusitis with nasal polyps (CRSwNP) and can improve patients' clinical symptoms and quality of life (QoL). The aim of this study was to
Yutong Sima, Jing Zhang, M. Zheng, Yan Zhao, Xiangdong Wang, Luo Zhang   +5 more
semanticscholar   +1 more source

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels : a pilot study [PDF]

, 2018
Background: Administration of the therapeutic anti-IgE antibody omalizumab to patients induces strong increases in IgE antibody levels. Objective: To investigate the effect of intranasal administration of major birch pollen allergen Bet v 1, omalizumab ...
Bischoff, Cameron, Chan, Chanez, Christianson, Chu, Dema, Eckl-Dorna, Egger, Egger, Gevaert, Ghetie, Gieras, Hauswirth, Hayashi, Humbert, Ishizaka, Jabara, Jardieu, Kaplan, Katona, KleinJan, Laffer, Lawrence, Lowe, Lupinek, MacGlashan, Mizuma, Naclerio, Nakamura, Narayanan, Niederberger, Noga, Noga, Ota, Platts-Mills, Steinberger, Stokes, Valent   +38 more
core   +1 more source

Diagnosis and management of eosinophilic asthma: a US perspective. [PDF]

, 2014
Eosinophilic asthma is now recognized as an important subphenotype of asthma based on the pattern of inflammatory cellular infiltrate in the airway. Eosinophilic asthma can be associated with increased asthma severity, atopy, late-onset disease, and ...
Doherty, Taylor A, Walford, Hannah H
core   +1 more source

Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies.

Journal of Allergy and Clinical Immunology: In Practice, 2021
BACKGROUND Assessment of clinical outcomes in the real-world corroborates findings from randomized controlled trials (RCTs). OBJECTIVE This meta-analysis evaluated real-world data of omalizumab on treatment response, lung function, exacerbations, oral ...
J. Bousquet, M. Humbert, P. Gibson, K. Kostikas, X. Jaumont, P. Pfister, F. Nissen   +6 more
semanticscholar   +1 more source

Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data [PDF]

, 2018
Background: The X‐ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1‐antihistamines. Methods: In X‐ACT, a phase III, double‐
Barbosa, Bernstein, Bork, Brooks, Choi, Finlay, Finlay, Grattan, Hallak, Herguner, James, Kaplan, Krieger, Maurer, Maurer, Maurer, McCormack, Metz, Metz, Saini, Saini, Shikiar, Staubach, Staubach, Weller, Weller, Weller, Zazzali, Zhao, Zuberbier   +29 more
core   +1 more source

A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad

Monaldi Archives for Chest Disease, 2020
Omalizumab proved to be very effective in improving control of severe atopic asthma. Many small-sized studies suggested a potential role for omalizumab in the management of aspirin-exacerbated respiratory disease. The aim of this study is to describe the
Paolo Cameli, Miriana d'Alessandro, Laura Bergantini, Elena Silvestri, Arianna Romaldi, Giacomo Emmi, Paola Parronchi, Elena Bargagli   +7 more
doaj   +1 more source

Treatment of estrogen-induced dermatitis with omalizumab [PDF]

, 2019
In 1945, Drs Bernhard Zondek and Yehuda Bromberg demonstrated intradermal treatment with estrone and estradiol benzoate induced urticarial lesions in some patients.1 Fifty years later, Shelley et al,2 who introduced the concept of progesterone dermatitis
Baker, William H., Bell, Maria C., Heskett, Jordan B., Mousdicas, Nico, Ocana, Jesus A., Turner, Matthew J.   +5 more
core   +1 more source

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

Allergy. European Journal of Allergy and Clinical Immunology
This study compared the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria.
Sarbjit S. Saini, M. Maurer, Yevgeniya Dytyatkovska, E. Springer, M. Ratkova, Borislava Krusheva, C. Park, Grażyna Pulka, Marta Chełmińska, A. Reich, Sunghyun Kim, K. Ahn, Suyoung Kim, Sewon Lee, Jieun Ka, Jongho Kim, Clive Grattan   +16 more
semanticscholar   +1 more source